ArticleNeurobiology of pain (Cambridge, Mass.)

Single-chain Fragment variable antibody targeting cholecystokinin-B receptor for pain reduction.

K N Westlund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.